RxAdvocate November, 2024 — Newsletter
FDA Approves New Drug for the Treatment of NASH
FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva
April Recognizes National Infertility Awareness Week
Easter Weekend and Family Time
RxConnection’s proactive approach to manage your prescription benefits will stay ahead of any escalating cost trends.
RxConnection offers a total package for managing your company’s prescription benefit.
› See all Rx Solutions
In today’s evolving world of prescription benefit management, focusing only on the financial aspect will put your company at a disadvantage.
As part of our clinically driven approach, RxConnection provides management controls for plan sponsors to achieve a sustainable pharmacy benefit.
Through our process, we bring clarity and eliminate inefficiencies that are embedded within pharmacy arrangements. Each RFP is customized to meet individual needs.
While most firms will simply review claims files for improvements in pricing, we see the critical need to also review for appropriate drug utilization.
Pharmacy contracts between the PBM and plan sponsor will define important features from pricing to how billing is performed. Our evaluation will expose optics used by PBMs.
An optimal solution for smaller-sized clients to achieve best in class pricing, service and contract clarity without going through a full RFP process.
FDA Approves New Drug for the Treatment of NASH
FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva
April Recognizes National Infertility Awareness Week
Easter Weekend and Family Time
Weight Loss Products: Should Employers Cover?